Red Meats and Processed Meat as the Carcinogenic Foods and Phytochemical-chemoprevention

Anna Meiliana, Nurrani Mustika Dewi, Andi Wijaya


BACKGROUND: Along with its increased prevalence, in the past decade, cancer had joined the list of chronic debilitating diseases. Nutrition become substantial aspects, due to its time-dependent effect to modulate inflammation thus trigger carcinogenic effects by altering the immune check point. Thus, nutrition contributes to the progression and therapeutic response of cancer, both in human or animal models.

CONTENT: Meat is well favored food with appreciable appealing. Due to its high nutritional values it plays a central role in human development. Meat or meat derivate are important sources of proteins, minerals and vitamins. Their nutritional importance is worth compare to their economic impact but recent publication of WHO has set the social alarm about the relationship between red and/or processed meat consumption and cancer. On the other side, some natural or biologic agents may inhibit or reverse tumor growth. Some phytochemical agents including curcumin, resveratrol, lycopene, folates and tea polyphenols clinically proved to tune the signaling pathways regulating cell proliferation and apoptosis in transformed cells, enhance the host immune system and sensitize malignant cells to cytotoxic agents.

SUMMARY: Recent studies on chemopreventive agents involves a wide range of molecules, natural (plants, fruits and vegetables) or synthetic will provide better insights for cancer early pathogenesis, important end-point biomarker, and finally potential for reducing the burden of cancer.

KEYWORDS: blocking agents, suppressing agents, red meat, processed meat, chemoprevention, phytochemicals

Full Text:



Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100: 57-70, CrossRef.

Hopkins BD, Concalves MD, Cantley LC. Obesity and cancer mechanisms: cancer metabolism. J Clin Oncol. 2016; 34: 4277-83, CrossRef.

Font-Burgada J, Sun B, Karin M. Obesity and Cancer: The Oil that Feeds the Flame. Cell Metab 2016; 23: 48-62, CrossRef.

Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature. 2015; 527: 186-91, CrossRef.

Peiris-Pagés M, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Metastasis and oxidative stress: are antioxidants a metabolic driver of progression? Cell Metab. 2015; 22: 956-8, CrossRef.

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-74, CrossRef.

Franchi L, Muñoz-Planillo R, Núñez G. Sensing and reacting to microbes through the inflammasomes. Nat Immunol. 2012; 13: 325-32, CrossRef.

Wen H, Ting JPY, O’Neill LAJ. A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation? Nat Immunol. 2012; 13: 352-7, CrossRef.

Rathinam VAK, Vanaja SK, Fitzgerald KA. Regulation of inflammasome signaling. Nat Immunol. 2012; 13: 333-42, CrossRef.

Zitvogel L, Kepp O, Galluzzi L, Kroemer G. Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol. 2012; 13: 343-51, CrossRef.

Alaejos MS, Afonso AM. Factors that affect the content of heterocyclic aromatic amines in foods. Comp Rev Food Sci Food Safe. 2011; 10: 52-108, CrossRef.

Alomirah H, Al-Zenki S, Al-Hooti S, Zaghloul S, Sawaya W, Ahmed N, et al. Concentrations and dietary exposure to polycyclic aromatic hydrocarbons (PAHs) from grilled and smoked foods. Food Control. 2011; 22: 2028-35, CrossRef.

Bouvard V, Loomis D, Guyton KZ, Grosse Y, El Ghissassi F, Benbrahim-Tallaa L, et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 2015; 115: 1599-600, CrossRef.

Benetou V, Lagiou A, Lagiou P. Chemoprevention of cancer: current evidence and future prospects. F1000Res. 2015; 4: 916, CrossRef.

Patterson SL, Colbert Maresso K, Hawk E. Cancer chemoprevention: successes and failures. Clin Chem. 2013; 59: 94-101, CrossRef.

Sporn MB, Suh N. Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer. 2002; 2: 537-43, CrossRef.

Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003; 3: 768-80, CrossRef.

De Melo FHM, Oliveira JS, Sartorelli VOB, Montor WR. Cancer chemoprevention: classic and epigenetic mechanisms inhibiting tumorigenesis. What have we learned so far? Front Oncol. 2018; 8: 644, CrossRef.

Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420: 860-7, CrossRef.

Mantovani A. Cancer: inflammation by remote control. Nature. 2005; 435: 752-3, CrossRef.

Schäfer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol. 2008; 9: 628-38, CrossRef.

Nathan C, Cunningham-Bussel A. Beyond oxidative stress: an immunologist’s guide to reactive oxygen species. Nat Rev Immunol. 2013; 13: 349-61, CrossRef.

Shivappa N, Steck SE, Hurley TG, Hussey JR, Hébert JR. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2013; 17: 1689-96, CrossRef.

Prieto I, Montemuiño S, Luna J, de Torres MV, Amaya E. The role of immunonutritional support in cancer treatment: current evidence. Clin Nutr. 2017; 36: 1457-64, CrossRef.

Zitvogel L, Pietrocola F, Kroemer G. Nutrition, inflammation and cancer. Nat Immunol. 2012; 18: 843-50, CrossRef.

Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010; 140: 883-99, CrossRef.

Coussens LM, Zitvogel L, Palucka AK. Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science. 2013; 339: 286-91, CrossRef.

Kolb R, Liu GH, Janowski AM, Sutterwala FS, Zhang W. Inflammasomes in cancer: a double-edged sword. Protein Cell. 2014; 5: 12-20, CrossRef.

Ferrone C, Dranoff G. Dual roles for immunity in gastrointestinal cancers. J Clin Oncol. 2010; 28: 4045-51, CrossRef.

Toyokuni S. Novel aspects of oxidative stress-associated carcinogenesis. Antioxid Redox Signal. 2010; 28: 1373-7, CrossRef.

Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med. 2010; 49: 1603-16, CrossRef.

Kubo N, Morita M, Nakashima Y, Kitao H, Egashira A, Saeki H, et al. Oxidative DNA damage in human esophageal cancer: clinicopathological analysis of 8-hydroxydeoxyguanosine and its repair enzyme. Dis Esophagus. 2013; 27: 285-93, CrossRef.

Matsui A, Ikeda T, Enomoto K, Hosoda K, Nakashima H, Omae K, et al. Increased formation of oxidative DNA damage, 8-hydroxy- 2'-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett. 2000; 151: 87-95, CrossRef.

Dziaman T, Huzarski T, Gackowski D, Rozalski R, Siomek A, Szpila A, et al. Elevated level of 8-oxo-7,8-dihydro-2'-deoxyguanosine in leukocytes of BRCA1 mutation carriers compared to healthy controls. Int J Cancer. 2009; 125: 2209-13, CrossRef.

Borrego S, Vazquez A, Dasí F, Cerdá C, Iradi A, Tormos C, et al. Oxidative stress and DNA damage in human gastric carcinoma: 8-Oxo-7'8-dihydro-2'-deoxyguanosine (8-oxo-dG) as a possible tumor marker. Int J Mol Sci. 2013; 14: 3467-86, CrossRef.

Wang M, Abbruzzese JL, Friess H, Hittelman WN, Evans DB, Abbruzzese MC, et al. DNA adducts in human pancreatic tissues and their potential role in carcinogenesis. Cancer Res. 1998; 58: 38-41, PMID.

Rivlin N, Brosh R, Oren M, Rotter V. Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis. Genes Cancer. 2011; 2: 466-74, CrossRef.

Le Calvez F, Mukeria A, Hunt JD, Kelm O, Hung RJ, Tanière P, et al. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res. 2005; 65: 5076-83, CrossRef.

Chikara S, Nagaprashantha LD, Singhal J, Horne D, Awasthi S, Singhal SS. Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment. Cancer Lett 2018; 413: 122-34, CrossRef.

Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013; 12: 931-47, CrossRef.

Motohashi H, Yamamoto M. Nrf2–Keap1 defines a physiologically important stress response mechanism. Trends Mol Med. 2004; 10: 549-57, CrossRef.

Jeong WS, Jun M, Kong AN. Nrf2: A potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal. 2006; 8: 99-106, CrossRef.

Zhang DD. Mechanistic studies of the Nrf2–Keap1 signaling pathway. Drug Metab Rev. 2006; 38: 769-89, CrossRef.

Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1–Nrf2– ARE pathway. Annu Rev Pharmacol Toxicol. 2007; 47: 89-116, CrossRef.

Lau A, Villeneuve NF, Sun Z, Wong PK, Zhang DD. Dual roles of Nrf2 in cancer. Pharmacol Res. 2008; 58: 262-70, CrossRef.

Jaramilo MC, Zhang DD. The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev. 2013; 27: 2179-91, CrossRef.

Hirayama A, Yoh K, Nagase S, Ueda A, Itoh K, Morito N, et al. EPR imaging of reducing activity in Nrf2 transcriptional factor-deficient mice. Free Radic Biol Med. 2003; 34: 1236-42, CrossRef.

Morito N, Yoh K, Itoh K, Hirayama A, Koyama A, Yamamoto M, et al. Nrf2 regulates the sensitivity of death receptor signals by affecting intracellular glutathione levels. Oncogene. 2003; 22: 9275-81, CrossRef.

Cho HY, Jedlicka AE, Reddy SP, Kensler TW, Yamamoto M, Zhang LY, et al. Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol. 2002; 26: 175-82, CrossRef.

Singh A, Misra V, Thimmulappa RK, Lee H, Ames S, Hoque MO, et al. Dysfunctional KEAP1-NRF2 interaction in non-small- cell lung cancer. PLoS Med. 2006; 3: e420, CrossRef.

Shibata T, Kokubu A, Gotoh M, Ojima H, Ohta T, Yamamoto M, et al. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology. 2008 135: 1358-68.e4, CrossRef.

Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K, et al. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci. 2008. 105: 13568-73, CrossRef.

Abid Z, Cross AJ, Sinha R. Meat, dairy, and cancer. Am J Clin Nutr. 2014; 100: 386S-93S, CrossRef.

Bernstein AM, Song M, Zhang X, Pan A, Wang M, Fuchs CS, et al. Processed and unprocessed red meat and risk of colorectal cancer: analysis by tumor location and modification by time. PLoS One. 2015; 10: e0135959, CrossRef.

English DR, MacInnis RJ, Hodge AM, Hopper JL, Haydon AM, Giles GG. Red meat, chicken, and fish consumption and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2004; 13: 1509-14, PMID.

Sandhu MS, White IR, McPherson K. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol Biomarkers Prev. 2001; 10: 439-46, PMID.

Watson AJM, Collins PD. Colon cancer: a civilization disorder. Dig Dis. 2011; 29: 222-8, CrossRef.

Bernstein C, Holubec H, Bhattacharyya AK, Nguyen H, Payne CM, Zaitlin B, et al. Carcinogenecity of deoxycholate, a secondary bile acid. Arch Toxicol. 2011; 85: 863-71, CrossRef.

Vipperla K, O’Keefe SJ. Intestinal microbes, diet, and colorectal cancer. Curr Colorectal Cancer Rep. 2013; 9: 95-105, CrossRef.

Hughes R, Magee EA, Bingham S. Protein degradation in the large intestine: relevance to colorectal cancer. Curr Issues Intest Microbiol. 2000; 1: 51-8, PMID.

Bos JL. Ras oncogenes in human cancer: a review. Cancer Res. 1989; 49: 4682-9, PMID.

Kobayashi J. Effect of diet and gut environment on the gastrointestinal formation of N-nitroso compounds: a review. Nitric Oxide. 2018; 73: 66-73, CrossRef.

Jeyakumar A, Dissabandara L, Gopalan V. A critical overview on the biological and molecular features of red and processed meat in colorectal carcinogenesis. J Gastroenterol. 2017; 52: 407-18, CrossRef.

Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol. 2011; 6: 479-507, CrossRef.

Lamprecht SA. Lipkin M. Migrating colonic crypt epithelial cells: primary targets for transformation. Carcinogenesis. 2002; 23: 1777-80, CrossRef.

Pierre F, Freeman A, Taché S, Van der Meer R, Corpet DE. Beef meat and blood sausage promote the formation of azoxymethane-induced mucin-depleted foci and aberrant crypt foci in rat colons. J Nutr. 2004; 134: 2711-6.

Gilsing AMJ, Fransen F, de Kok TM, Goldbohm AR, Schouten LJ, de Bruine AP, et al. Dietary heme iron and the risk of colorectal cancer with specific mutations in KRAS and APC. Carcinogenesis. 2013; 34: 2757-66, CrossRef.

Schneikert J, Behrens J. The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut. 2007; 56: 417-25, CrossRef.

Gamage SMK, Dissabandara L, Lam AKY, Gopalan V. The role of heme iron molecules derived from red and processed meat in the pathogenesis of colorectal carcinoma. Crit Rev Oncol Hematol. 2018; 126: 121-8, CrossRef.

Sporn MB, Dunlop NM, Newton DL, Smith JM. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc. 1976; 35: 1332-8, PMID.

Landis-Piwowar KR, Iyer N. Cancer chemoprevention: current state of the art. Cancer Growth Metastasis. 2014; 7: 19-25, CrossRef.

De Flora S, Ferguson LR. Overview of mechanisms of cancer chemopreventive agents. Mutat Res. 2005; 591: 8-15, CrossRef.

Steward WP, Brown K. Cancer chemoprevention: a rapidly evolving field. Br J Cancer. 2013; 109: 1-7, CrossRef.

Shu L, Cheung KL, Khor TO, Chen C, Kong AN. Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis. Cancer Metastasis Rev. 2010; 29: 483-502, CrossRef.

Vanden Berghe W. Epigenetic impact of dietary polyphenols in cancer chemoprevention: lifelong remodeling of our epigenomes. Pharmacol Res. 2012; 65: 565-76, CrossRef.

Gan FF, Ling H, Ang X, Reddy SA, Lee SSH, Yang H, et al. A novel shogaol analog suppresses cancer cell invasion and inflammation, and displays cytoprotective effects through modulation of NF-kB and Nrf2-Keap1 signaling pathways. Toxicol Appl Pharmacol. 2013; 272: 852-62, CrossRef.

Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006; 354: 270-82, CrossRef.

Din FVN, Valanciute A, Houde VP, Zibrova D, Green KA, Sakamoto K, et al. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. Gastroenterology. 2012; 142: 1504-15.e3, CrossRef.

Yang H, Landis-Piwowar K, Chan TH, Dou QP. Green tea polyphenols as proteasome inhibitors: implication in chemoprevention. Curr Cancer Drug Targets. 2011; 11: 296-306, CrossRef.

Bruno RD, Njar VC. Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development. Bioorg Med Chem. 2007; 15: 5047-60, CrossRef.

Landis-Piwowar K, Chen D, Chan TH, Dou QP. Inhibition of catechol-omicron-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG. Oncol Rep. 2010; 24: 563-69, CrossRef.

Kuang S, Qi C, Liu J, Sun X, Zhang Q, Sima Z, et al. 2-Methoxystypandrone inhibits signal transducer and activator of transcription 3 and nuclear factor-κB signaling by inhibiting Janus kinase 2 and IκB kinase. Cancer Sci. 2014; 105: 473-80, CrossRef.

Wu DG, Yu P, Li JW, Jiang P, Sun J, Wang HZ, et al. Apigenin potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells. Toxicol Lett. 2014; 224: 157-64, CrossRef.

Jaramillo MC, Zhang DD. The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev. 2013; 27: 2179-91, CrossRef.

Dinkova-Kostova AT, Fahey JW, Kostov RV, Kensler TW. KEAP1 and done? targeting the NRF2 pathway with sulforaphane. Trends Food Sci Technol. 2017; 69: 257-69, CrossRef.

Sohn EJ, Park HT. Natural agents mediated autophagic signal networks in cancer. Cancer Cell Int. 2017; 17: 110, CrossRef.

Deep G, Gangar SC, Agarwal C, Agarwal R. Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells. Cancer Prev Res. 2011; 4: 1222-32, CrossRef.

Zhu FQ, Chen MJ, Zhu M, Zhao RS, Qiu W, Xu X, et al. Curcumin suppresses epithelial-mesenchymal transition of renal tubular epithelial cells through the inhibition of Akt/mTOR pathway. Biol Pharm Bull. 2017; 40: 17-24, CrossRef.

Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, et al. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF- β1/Smads signaling pathway mediated Snail/E-cadherin expression. BMC Cancer. 2015; 15: 97, CrossRef.

Jaramillo MC, Zhang DD. The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev. 2013; 27: 2179-91, CrossRef.

Nguyen T, Nioi P, Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem. 2009; 284: 13291-5, CrossRef.

Baylin SB, Jones PA. A decade of exploring the cancer epigenome-biological and translational implications. Nat Rev Cancer. 2011; 11: 726-34, CrossRef.

Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002; 3: 415-28, CrossRef.

Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007; 128: 683-92, CrossRef.

Wellen KE, Thompson CB. Cellular metabolic stress: considering how cells respond to nutrient excess. Mol Cell. 2010; 40: 323-32, CrossRef.

Azad N, Zahnow CA, Rudin CM, Baylin SB. The future of epigenetic therapy in solid tumours—lessons from the past. Nat Rev Clin Oncol. 2013; 10: 256-66, CrossRef.

Ahuja N, Easwaran H, Baylin SB. Harnessing the potential of epigenetic therapy to target solid tumors. J Clin Invest. 2014; 124: 56-63, CrossRef.

Michels KB, Mohllajee AP, Roset-Bahmanyar E, Beehler GP, Moysich KB. Diet and breast cancer: a review of the prospective observational studies. Cancer. 2007; 109: 2712-49, CrossRef.

Vainio H, Weiderpass E. Fruit and vegetables in cancer prevention. Nutr Cancer. 2006; 54: 111-42, CrossRef.

Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr. 2004; 134: 3479S-85S, CrossRef.

Kim MK, Park JH. Cruciferous vegetable intake and the risk of human cancer: epidemiological evidence. Proc Nutr Soc. 2009; 68: 103-10, CrossRef.

Liu X, Ly K. Cruciferous vegetables intake is inversely associated with risk of breast cancer: a meta-analysis. The Breast. 2013; 22: 309-13, CrossRef.

Kirsh VA, Peters U, Mayne ST, Subar AF, Chatterjee N, Johnson CC, et al. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst. 2007; 99: 1200-9, CrossRef.

Verhoeven DT, Verhagen H, Goldbohm RA, van den Brandt PA, van Poppel G. A review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem Biol Interact. 1997; 103: 79-129, CrossRef.

Talalay P, Fahey JW, Holtzclaw WD, Prestera T, Zhang Y. Chemoprotection against cancer by phase 2 enzyme induction. Toxicol Lett. 1995; 82-83: 173-9, PMID.

Zhang Y, Talalay P. Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. Cancer Res. 1994; 54: 1976s-81s, PMID.

Fowke JH, Longcope C, Hebert JR. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2000; 9: 773-9, PMID.

Meng Q, Yuan F, Goldberg ID, Rosen EM, Auborn K, Fan S. Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells. J Nutr. 2000; 130: 2927-31, CrossRef.

Hsing AW, McLaughlin JK, Schuman LM, Bjelke E, Gridley G, Wacholder S, et al. Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res. 1990; 50: 6836-40, PMID.

Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC. A prospective study of cruciferous vegetables and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2003; 12: 1403-9, PMID.

Stram DO, Hankin JH, Wilkens LR, Park S, Henderson BE, Nomura AMY, et al. Prostate cancer incidence and intake of fruits, vegetables and related micronutrients: the multiethnic cohort study* (United States). Cancer Causes Control. 2006; 17: 1193-207, CrossRef.

Riso P, Martini D, Moller P, Loft S, Bonacina G, Moro M, et al. DNA damage and repair activity after broccoli intake in young healthy smokers. Mutagenesis. 2010; 25: 595-602, CrossRef.

Munday R, Mhawech-Fauceglia P, Munday CM, Paonessa JD, Tang L, Munday JS, et al. Inhibition of urinary bladder carcinogenesis by broccoli sprouts. Cancer Res. 2008; 68: 1593-600, CrossRef.

Wakabayashi N, Slocum SL, Skoko JJ, Shin S, Kensler TW.When NRF2 talks, who's listening? Antioxid Redox Signal. 2010; 13: 1649-63, CrossRef.

Licznerska B, Szaefer H, Matuszak I, Murias M, Baer-Dubowska W. Modulating potential of L-sulforaphane in the expression of cytochrome p450 to identify potential targets for breast cancer chemoprevention and therapy using breast cell lines. Phytother Res. 2015; 29: 93-9, CrossRef.

Seeram NP, Henning SM, Niu Y, Lee R, Scheuller HS, Heber D. Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity. J Agric Food Chem. 2006; 54: 1599-603, CrossRef.

Wang LG, Liu XM, Chiao JW. Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate. Carcinogenesis. 2006; 27: 2124-32, CrossRef.

Hwang ES, Lee HJ. Effects of phenylethyl isothiocyanate and its metabolite on cell-cycle arrest and apoptosis in LNCaP human prostate cancer cells. Int J Food Sci Nutr. 2010; 61: 324-36, CrossRef.

Gibbs A, Schwartzman J, Deng V, Alumkal J. Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6. Proc Natl Acad Sci USA. 2009; 106: 16663-8, CrossRef.

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65: 87-108, CrossRef.

Aleksandrova K, Pischon T, Jenab M, Bueno-de-Mesquita HB, Fedirko V, Norat T, et al. Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study. BMC Med. 2014; 12: 168, CrossRef.

Garcia DO, Thomson CA. Physical activity and cancer survivorship. Nutr Clin Pract. 2014; 29: 768-79, CrossRef.

Mehta M, Shike M. Diet and physical activity in the prevention of colorectal cancer. J Natl Compr Canc Netw. 2014; 12: 1721-6, CrossRef.

Howes MJ, Simmonds MS. The role of phytochemicals as micronutrients in health and disease. Curr Opin Clin Nutr Metab Care. 2014; 17: 558-66, CrossRef.

Murakami A. Chemoprevention with phytochemicals targeting inducible nitric oxide synthase. Forum Nutr. 2009; 61: 193-203, CrossRef.

Priyadarsini RV, Nagini S. Cancer chemoprevention by dietary phytochemicals: promises and pitfalls. Curr Pharm Biotechnol. 2012; 13: 125-36, CrossRef.

Lee KW, Bode AM, Dong Z. Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer. 2011; 11: 211-8, CrossRef.

Loeb LA, Harris CC. Advances in chemical carcinogenesis: a historical review and prospective. Cancer Res. 2008; 68: 6863-72, CrossRef.

Tokarz P, Blasiak J. Role of mitochondria in carcinogenesis. Acta Biochim Pol. 2014; 61: 671-8, CrossRef.

Barcellos-Hoff MH, Lyden D, Wang TC. The evolution of the cancer niche during multistage carcinogenesis. Nat Rev Cancer. 2013; 13: 511-8, CrossRef.

Kotecha R, Takami A, Espinoza JL. Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget. 2016; 7: 52517-29, CrossRef.

Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology. 2007; 121: 1-14, CrossRef.

Collins AR, Azqueta A, Langie SA. Effects of micronutrients on DNA repair. Eur J Nutr. 2012; 51: 261-79, CrossRef.

Royston KJ, Tollefsbol TO. The epigenetic impact of cruciferous vegetables on cancer prevention. Curr Pharmacol Rep. 2015; 1: 46-51, CrossRef.

Luis Espinoza J, Takami A, Trung LQ, Nakao S. Ataxia-telangiectasia mutated kinase-mediated upregulation of NKG2D ligands on leukemia cells by resveratrol results in enhanced natural killer cell susceptibility. Cancer Sci. 2013; 104: 657-62, CrossRef.

Slamenova D, Horvathova E. Cytotoxic, anti-carcinogenic and antioxidant properties of the most frequent plant volatiles. Neoplasma. 2013; 60: 343-354, CrossRef.

Chen D, Daniel KG, Chen MS, Kuhn DJ, Landis-Piwowar KR, Dou QP. Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. Biochem Pharmacol. 2005; 69: 1421-32, CrossRef.

Chan SN, Tang BL. Location and membrane sources for autophagosome formation—from ER-mitochondria contact sites to Golgi-endosome-derived carriers. Mol Membr Biol. 2013; 30: 394-402, CrossRef.

Gao H, Sun W, Zhao W, Hao W, Leung CH, Lu J, et al. Total tanshinones-induced apoptosis and autophagy via reactive oxygen species in lung cancer 95D cells. Am J Chin Med. 2015; 43: 1265-79, CrossRef.

Meng Y, Lin ZM, Ge N, Zhang DL, Huang J, Kong F. Ursolic acid induces apoptosis of prostate cancer cells via the PI3K/Akt/mTOR pathway. Am J Chin Med. 2015; 43: 1471-86, CrossRef.

Wang K, Liu R, Li J, Mao J, Lei Y, Wu J, et al. Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR-and hypoxia-induced factor 1alpha-mediated signaling. Autophagy. 2011; 7: 966-78, CrossRef.

Suh Y, Afaq F, Khan N, Johnson JJ, Khusro FH, Mukhtar H. Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells. Carcinogenesis. 2010; 31: 1424-33, CrossRef.

Ge J, Liu Y, Li Q, Guo X, Gu L, Ma ZG, et al. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK. Biomed Environ Sci BES. 2013; 26: 902-11, CrossRef.

Yeh PS, Wang W, Chang YA, Lin CJ, Wang JJ, Chen RM. Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migration. Cancer Lett. 2016; 370: 66-77, CrossRef.

Zheng X, Chen W, Hou H, Li J, Li H, Sun X, et al. Ginsenoside 20(S)- Rg3 induced autophagy to inhibit migration and invasion of ovarian cancer. Biomed Pharmacother Biomed Pharmacother. 2017; 85: 620-6, CrossRef.

Xavier CP, Lima CF, Pedro DF, Wilson JM, Kristiansen K, Pereira-Wilson C. Ursolic acid induces cell death and modulates autophagy through JNK pathway in apoptosis-resistant colorectal cancer cells. J Nutr Biochem. 2013; 24: 706-12, CrossRef.

Zheng K, Li Y, Wang S, Wang X, Liao C, Hu X, et al. Inhibition of autophagosome-lysosome fusion by ginsenoside Ro via the ESR2-NCF1-ROS pathway sensitizes esophageal cancer cells to 5-fluorouracil-induced cell death via the CHEK1-mediated DNA damage checkpoint. Autophagy. 2016; 12: 1593-613, CrossRef.

Shehzad A, Wahid F, Lee YS. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim). 2010; 343: 489-99, CrossRef.

Bar-Sela G, Epelbaum R, Schaffer M. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr Med Chem. 2010; 17: 190-7, CrossRef.

Hasima N, Aggarwal BB. Targeting proteasomal pathways by dietary curcumin for cancer prevention and treatment. Curr Med Chem. 2014; 21: 1583-94, CrossRef.

Bortel N, Armeanu-Ebinger S, Schmid E, Kirchner B, Frank J, Kocher A, et al. Effects of curcumin in pediatric epithelial liver tumors: inhibition of tumor growth and alpha-fetoprotein in vitro and in vivo involving the NFkappaB- and the beta-catenin pathways. Oncotarget. 2015; 6: 40680-91, CrossRef.

Keylor MH, Matsuura BS, Stephenson CR. Chemistry and biology of resveratrol-derived natural products. Chem Rev. 2015; 115: 8976-9027, CrossRef.

Espinoza JL, Takami A, Trung LQ, Kato S, Nakao S. Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells. PLoS One. 2012; 7: e51306, CrossRef.

Scott E, Steward WP, Gescher AJ, Brown K. Resveratrol in human cancer chemoprevention--choosing the ‘right’ dose. Mol Nutr Food Res. 2012; 56: 7-13, CrossRef.

Shukla Y, Singh R. Resveratrol and cellular mechanisms of cancer prevention. Ann NY Acad Sci. 2011; 1215: 1-8, CrossRef.

Kato A, Naiki-Ito A, Nakazawa T, Hayashi K, Naitoh I, Miyabe K, et al. Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3β and ERK1/2. Oncotarget. 2015; 6: 42963-75, CrossRef.

Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, Brown K. Clinical trials of resveratrol. Ann NY Acad Sci. 2011; 1215: 161-9, CrossRef.

Seeni A, Takahashi S, Takeshita K, Tang M, Sugiura S, Sato SY, et al. Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. Asian Pac J Cancer Prev. 2008; 9: 7-14, PMID.

Seeram NP, Henning SM, Niu Y, Lee R, Scheuller HS, Heber D. Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity. J Agric Food Chem. 2006; 54: 1599-603, CrossRef.

Wu AH, Yu MC. Tea, hormone-related cancers and endogenous hormone levels. Mol Nutr Food Res. 2006; 50: 160-9, CrossRef.

Yiannakopoulou EC. Effect of green tea catechins on breast carcinogenesis: a systematic review of in-vitro and in-vivo experimental studies. Eur J Cancer Prev. 2014; 23: 84-9, CrossRef.

Steele VE, Kelloff GJ, Balentine D, Boone CW, Mehta R, Bagheri D, et al. Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis. 2000; 21: 63-7, CrossRef.

Glasauer A, Chandel NS. Targeting antioxidants for cancer therapy. Biochem Pharmacol. 2014; 92: 90-101, CrossRef.

Bailey LB, Gregory JF. Folate metabolism and requirements. J Nutr. 1999; 129: 779-82, CrossRef.

Dary O. Nutritional interpretation of folic acid interventions. Nutr Rev. 2009; 67: 235-44, CrossRef.

Chen P, Li C, Li X, Li J, Chu R, Wang H. Higher dietary folate intake reduces the breast cancer risk: a systematic review and meta-analysis. Br J Cancer. 2014; 110: 2327-38, CrossRef.

Shi J, Le Maguer M. Lycopene in tomatoes: chemical and physical properties affected by food processing. Crit Rev Biotechnol. 2000; 20: 293-334, CrossRef.

Palozza P, Parrone N, Catalano A, Simone R. Tomato lycopene and inflammatory cascade: basic interactions and clinical implications. Curr Med Chem. 2010; 17: 2547-63, CrossRef.

Ono M, Takeshima M, Nakano S. Mechanism of the anticancer effect of lycopene (tetraterpenoids). Enzymes. 2015; 37: 139-66, CrossRef.

Key TJ, Appleby PN, Travis RC, Albanes D, Alberg AJ, Barricarte A, et al. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies. Am J Clin Nutr. 2015; 102: 1142-57, CrossRef.

Chen J, Song Y, Zhang L. Lycopene/tomato consumption and the risk of prostate cancer: a systematic review and meta-analysis of prospective studies. J Nutr Sci Vitaminol. 2013; 59: 213-23, CrossRef.

Ilic D, Forbes KM, Hassed C. Lycopene for the prevention of prostate cancer. Cochrane Database Syst Rev. 2011: 2011; CD008007, CrossRef.

Budhraja A, Gao N, Zhang Z, Son Y-O, Cheng S, Wang X, et al. Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo. Mol Cancer Ther. 2012; 11: 132-42, CrossRef.

Byun S, Park J, Lee E, Lim S, Yu JG, Lee SJ, et al. Src kinase is a direct target of apigenin against UVB-induced skin inflammation. Carcinogenesis. 2013; 34: 397-405, CrossRef.

Shukla S, Gupta S. Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft. Mol Cancer Ther. 2006; 5: 843-5, CrossRef.

Shukla S, MacLennan GT, Flask CA, Fu P, Mishra A, Resnick MI, et al. Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. Cancer Res. 2007; 67: 6925-35, CrossRef.

Nicholas C, Batra S, Vargo MA, Voss OH, Gavrilin MA, Wewers MD, et al. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kB through the suppression of p65 phosphorylation. J Immunol. 2007; 179: 7121-7, CrossRef.

Lee SH, Ryu JK, Lee K-Y, Woo SM, Park JK, Yoo JW, et al. Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer. Cancer Lett. 2008; 259: 39-49, CrossRef.

Ruiz PA, Haller D. Functional diversity of flavonoids in the inhibition of the proinflammatory NF-kB, IRF, and Akt signaling pathways in murine intestinal epithelial cells. J Nutr. 2006; 136: 664-71, CrossRef.

Shukla S, Gupta S. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor NF-kB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kB-responsive genes. Clin Cancer Res. 2004; 10: 3169-78, CrossRef.


Indexed by:






The Prodia Education and Research Institute